Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature

Department of Medicine II, S. Chiara General Hospital, Trento, Italy.

A 17-year-old girl was admitted to our department with a hemorrhagic syndrome due to a serious coagulopathy; prothrombin time (PT) INR was 2.46 and the activated partial thromboplastin time (aPTT) ratio 3.46. Coagulation tests with pooled normal fresh plasma did not correct aPTT because of a coagulation inhibitor, and only partially corrected PT. Factor II activity reached only 5%. Diluted Russell viper venom tests (dRVVT) and kaolin clotting time (KCT) of patient plasma (PP) and of a mixture of PP/normal plasma (NP) detected the lupus anticoagulant (LA). The level of factor II antigen was 10%. We diagnosed systemic lupus erythematosus (SLE) with a rare acquired hypoprothrombinemia-LA syndrome (HLAS). The patient was treated with corticosteroids and high-dose Ig and a normal PT value was re-established.

This article has been cited by other articles:

				T. Avcin and E. Silverman Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome Lupus, August 1, 2007; 16(8): 627 - 633. [Abstract] [PDF]

				M. Bhattacharya, A. Biswas, M. Kannan, P. Mishra, A. Kumar, V. P. Choudhry, and R. Saxena Clinicohematologic Spectrum in Patientswith Lupus Anticoagulant Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 191 - 195. [Abstract] [PDF]

				J. R. Yacobovich, Y. Uziel, Z. Friedman, J. Radnay, and B. Wolach Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome Rheumatology, May 1, 2001; 40(5): 585 - 587. [Abstract] [Full Text] [PDF]

				Y. Sherer, Y. Levy, and Y. Shoenfeld Intravenous immunoglobulin therapy of antiphospholipid syndrome Rheumatology, April 1, 2000; 39(4): 421 - 426. [Abstract] [Full Text] [PDF]